Retraction Note: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Retraction Note: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment ; day:16 ; month:9 ; year:2023 ; pages:1
Cancer chemotherapy and pharmacology ; (16.9.2023), 1
- Urheber
-
Oya, Mototsugu
Kaneko, Shuichi
Imai, Tsuneo
Tsujino, Toshiaki
Sunaya, Toshiyuki
Okayama, Yutaka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-023-04587-8
- URN
-
urn:nbn:de:101:1-2023112914443311850583
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oya, Mototsugu
- Kaneko, Shuichi
- Imai, Tsuneo
- Tsujino, Toshiaki
- Sunaya, Toshiyuki
- Okayama, Yutaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Treatment of renal angiomyolipoma: pooled analysis of individual patient data
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells
Interrelationship between thyroid hormones and reduced renal function, a review article
Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Treatment of renal angiomyolipoma: pooled analysis of individual patient data
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells
Interrelationship between thyroid hormones and reduced renal function, a review article
Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Treatment of renal angiomyolipoma: pooled analysis of individual patient data
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Extremely Low Birth Weight Predisposes to Impaired Renal Health: A Pooled Analysis
Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells